Follicum AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Subsidiary
- Established
- 2004-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.follicum.com
A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers
Phase 2
Completed
- Conditions
- Androgenetic Alopecia
- Interventions
- Drug: Topical formulation
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2021-03-01
- Lead Sponsor
- Follicum AB
- Target Recruit Count
- 209
- Registration Number
- NCT04774874
- Locations
- 🇩🇪
ProDerm GmbH, Hamburg, Germany
To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Follicum AB
- Target Recruit Count
- 60
- Registration Number
- NCT03467412
- Locations
- 🇩🇪
Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin, Berlin, Germany
🇩🇪Bioskin GmbH, Hamburg, Germany
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
- First Posted Date
- 2016-06-08
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Follicum AB
- Target Recruit Count
- 44
- Registration Number
- NCT02793557
- Locations
- 🇩🇪
Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin, Berlin, Germany
© Copyright 2025. All Rights Reserved by MedPath